Biosimilar and Biologics Market Is Expected to Reach USD 1,060.7...

shared a link

2025-01-08 16:34:56 -

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and biologics will likely increase at 7.6% CAGR during the forecast period, taking the overall market valuation to a staggering USD 1,060.7 billion by 2034.

https://www.globenewswire.com/en/news-release/2024/08/27/2936411/0/en/Biosimilar-and-Biologics-Market-Is-Expected-to-Reach-USD-1-060-7-Billion-by-2034-And-Grow-at-a-Compound-Annual-Growth-Rate-of-7-6-FMI-Inc.html

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and biologics will likely increase at 7.6% CAGR during the forecast period, taking the overall market valuation to a staggering USD 1,060.7 billion by 2034. https://www.globenewswire.com/en/news-release/2024/08/27/2936411/0/en/Biosimilar-and-Biologics-Market-Is-Expected-to-Reach-USD-1-060-7-Billion-by-2034-And-Grow-at-a-Compound-Annual-Growth-Rate-of-7-6-FMI-Inc.html

WWW.GLOBENEWSWIRE.COM

The pharmaceutical industry has made significant strides in biosimilars and biologics, offering opportunities for innovation, growth, and enhanced patient...

0 Comments 0 Shares 24 Views 0 Reviews